An important feature of the mammary gland is its ability to undergo profound morphological, physiological, and intracellular changes to establish and maintain secretory function. During this process, key polarity proteins and receptors are recruited to the surface of mammary epithelial cells (MECs), and the vesicle transport system develops and matures. However, the intracellular mechanisms responsible for the development of secretory function in these cells are unclear. The vesicular zinc (Zn 2؉ ) transporter ZnT2 is critical for appropriate mammary gland architecture, and ZnT2 deletion is associated with cytoplasmic Zn 2؉ accumulation, loss of secretory function and lactation failure. The underlying mechanisms are important to understand as numerous mutations and non-synonymous genetic variation in ZnT2 have been detected in women that result in severe Zn 2؉ deficiency in exclusively breastfed infants. Here we found that ZnT2 deletion in lactating mice and cultured MECs resulted in Zn 2؉ -mediated degradation of phosphatase and tensin homolog (PTEN), which impaired intercellular junction formation, prolactin receptor trafficking, and alveolar lumen development. Moreover, ZnT2 directly interacted with vacuolar H ؉ -ATPase (V-ATPase), and ZnT2 deletion impaired vesicle biogenesis, acidification, trafficking, and secretion. In summary, our findings indicate that ZnT2 and V-ATPase interact and that this interaction critically mediates polarity establishment, alveolar development, and secretory function in the lactating mammary gland. Our observations implicate disruption in ZnT2 function as a modifier of secretory capacity and lactation performance.
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In many highly-specialized eukaryotic cells, secretory function is mediated through regulated vesicle trafficking (1) , which first requires the establishment of epithelial cell polarity (2) (3) (4) (5) . In the mammary gland, mammary epithelial cell (MEC) 3 polarity develops primarily during late pregnancy/early lactation (6, 7) and is characterized by the formation of adherence and tight junctions followed by luminal expansion (reviewed in Refs. 2, 4, and 8). Polarity is critical for both establishing the secretion of milk components into the alveolar lumen and concurrently, limiting the passage of solutes, such as sodium and chloride, from the basolateral bloodstream (9) . Several well-described factors involved in polarity establishment, such as phosphatase and tensin homolog (PTEN), cell division control protein homologue 42 (Cdc42), and annexins (2, 10) , are critical regulators of MEC integrity and function (3, 11, 12) . Second, to complete the development of secretory function, the vesicle secretion system must be established. In neurons and pituitary cells, vesicle secretion is predicated upon vesicle acidification (13) (14) (15) (16) . This process is dependent upon vacuolar H ϩ -ATPase (V-ATPase), a proton pump that is responsible for the development of a proton gradient across intracellular membranes (17, 18) . We previously showed that V-ATPase is expressed in MECs (19) and more recently, V-ATPase was implicated in mammary gland development (20) . However, the specific role of V-ATPase in the mammary gland is not well-understood, and a direct role for V-ATPase in secretion during lactation has not been shown.
Impairments in secretory function can lead to suboptimal lactation (21, 22) or overt lactation failure (23, 24) . Emerging evidence suggests that disturbances in mammary gland zinc (Zn 2ϩ ) homeostasis compromise secretory function (25) (26) (27) (28) (29) (30) . Zinc is an essential ion that is required by 10% of the eukaryotic proteome and plays a vital role in over 300 cellular processes (e.g. transcription, translation, enzyme activity, and intracellular signaling) and cellular functions (e.g. proliferation, polarity, apoptosis, and differentiation). One protein that is critical for Zn 2ϩ management in the mammary gland is the vesicle Zn 2ϩ transporter ZnT2 (SLC30A2) (31) (32) (33) . ZnT2 expression is restricted to highly-specialized secretory tissues, such as the pancreas, prostate, placenta, ovary, and mammary gland (34) . ZnT2 has six transmembrane domains (35) and functions as a dimer to transport Zn 2ϩ from the cytoplasm into vesicles (30, 32, 33) . ZnT2-null mice accumulate cytoplasmic Zn 2ϩ in MECs in vivo, which is associated with impaired intracellular organization and reduced STAT5 signaling, leading to defects in mammary gland architecture, impaired secretion, altered milk composition, and lactation failure. This is consistent with reports in ZnT2-attenuated MECs in vitro, in which cytoplasmic Zn 2ϩ levels are increased and associated with reduced STAT5 activation and secretion. These observations collectively implicate ZnT2 in prolactin receptor (PRLR)-mediated establishment of MEC polarity and secretory function (27) .
The identification of several mutations in SLC30A2, that reduce milk Zn 2ϩ concentration (26, 30, 36, 37) and lead to increased infant morbidity (38, 39) , underlies the clinical importance of understanding the role and regulation of ZnT2. Moreover, we recently reported that expression of non-synonymous variants in SLC30A2 is surprisingly common (29) . Studies in vitro found that many of these ZnT2 variants result in subcellular Zn 2ϩ redistribution and cytotoxic Zn 2ϩ accumulation (29, 40) . Intriguingly, several ZnT2 variants are associated with elevated milk sodium levels, a hallmark of breast dysfunction during lactation (41) (42) (43) , implicating defects in ZnT2-mediated intracellular Zn 2ϩ management as a modifier of MEC function.
In this study, we hypothesized that ZnT2 plays a direct role in establishing secretory function. We demonstrated that loss of ZnT2-mediated Zn 2ϩ transport lead to PTEN degradation and impaired recruitment of apical polarity proteins, which interfered with the proper establishment of polarity and PRLR trafficking to the cell surface. Most interestingly, we found that ZnT2 is critical for V-ATPase assembly and vital for secretory vesicle biogenesis, acidification and secretion.
Results and discussion

Loss of ZnT2 disrupts junction formation and lumen development in the mammary gland in vivo
The mammary glands from lactating ZnT2-null mice have profound defects in secretory function, including a lack of lobulo-alveolar structures and severe disorganization of intracellular vesicles and organelles, which is associated with impaired milk secretion (27) . Establishing MEC polarity is important for the development of secretory function and producing adequate milk volume (44 -46) . In the mammary gland, a primary hallmark of reduced MEC polarity is impaired alveolar expansion (44) . Consistent with this, we found that 60% of the mammary gland alveoli in ZnT2ko mice failed to expand (Fig. 1, A and B) , as their luminal area was significantly smaller compared with their wt littermates (Fig. 1C) . Key molecules important for MEC polarity are E-cadherin, an adherence junction protein located specifically in the basolateral region, and zonula occludens 1 (ZO-1), a tight junction protein located apico-laterally. Mislocalization of E-cadherin and ZO-1 indicates disrupted intercellular adhesion and apical-basolateral segregation (44) . As expected, these proteins were located to their respective subdomain in the mammary epithelia of wt mice (Fig. 1D , i-ii, and E, i-iii). However, in ZnT2ko mice, lateral staining of E-cadherin was lacking (Fig. 1D, iii-iv) , and ZO-1 was retained in discrete cytoplasmic regions in MECs (Fig. 1E, v-vii) . These defects in intercellular adhesion and lumen development were further revealed at the subcellular level using transmission electron microscopy. Mammary glands from wt mice illustrate fully functional and mature alveoli with vastly expanded lumen, which are lined by polarized MECs linked together by intact tight and adherens junctions on the lateral surface (Fig. 1F, i-ii) . In contrast, ZnT2ko mice had poorly expanded alveoli that lacked defined junctions between adjacent cells (Fig. 1F, iii-iv) . Collectively, this provides compelling evidence that MEC polarity was impaired in the mammary glands of ZnT2-null mice.
ZnT2-mediated Zn
2؉ transport maintains PTEN stability and the development of polarity Polarity and the establishment of secretory function in MECs are stimulated by PRL (47, 48) . To identify mechanisms through which the loss of ZnT2 leads to impairs MEC polarity and lumen development, HC11 cells were cultured on Matrigel then treated with PRL, and the ability to form 3D mammospheres with mature alveoli was assessed ( Fig. 2A) . ZnT2-expressing MECs formed well-organized mature mammospheres complete with an expanded lumen and appropriate polarization (Fig. 2B) . In contrast, ZnT2-attenuated cells did not form polarized and mature alveoli (Fig. 2 , C and D) and ϳ90% of ZnT2KD mammospheres failed to form a lumen in 3D culture (Fig. 2E) . Consistent with our observations in vivo, we found that ZnT2-expressing cells in 2D culture formed intercellular junctions, indicated by the contiguous staining of both E-cadherin (Fig. 2F) , and ZO-1 at the cell surface (Fig. 2G ) in response to PRL treatment. In contrast, ZnT2-attenuated cells lacked contiguous cell-surface staining of both E-cadherin and ZO-1. This observation begs the question as to the identity of the primary defect in MECs that lack ZnT2 expression.
In epithelial cells, three major polarity complexes, PAR, Crumbs, and Scribble (10), regulate apical-basolateral organization and asymmetric segregation of the cell membrane, intracellular organelles, and the cytoskeleton (2), and coordinate cell cycle progression (40) . Of these major polarity complexes, the PAR complex is the most well-characterized in epithelial cells, and responsible for the recruitment of PTEN to the cell membrane (5, 49, 50) . Under normal conditions, cytosolic PTEN translocates to the cell membrane via myosin-based transport machinery (51) , where it transiently associates with the cell membrane and acts as a lipid phosphatase to hydrolyze phosphatidylinositol (3,4,5)-triphosphate to phosphatidylinositol (3,5)-diphosphate, antagonizing the PI3K/Akt pathway (50) . PTEN-mediated epithelial polarization promotes proper localization of molecular factors and subcellular organelles that allow cells to efficiently respond to secretory differentiation cues for alveolar development (52) . During polarity establishment, PTEN directs the enrichment of proteins to the apical membrane by recruiting Axn2, which in turn recruits Cdc42, a small GTPase of the Rho family that regulates signaling pathways that control diverse cellular functions including cell morphology, migration, endocytosis, and cell cycle progression (53) . Ultimately this sequence of events activates the PAR complex (49) , which is vital for the process of alveologenesis (54) . In the mammary epithelium, PTEN exerts these effects through several signaling pathways, such as mitogen-activated protein ZnT2 regulates secretory function kinases (MAPK), focal adhesion kinase (FAK), and PI3K-AKT, playing a critical role in mammary development and lactation (55, 56) . Loss of PTEN expression inhibits cell polarization, functional differentiation, and tissue development (57) (58) (59) . In addition, PTEN is one of the most frequently mutated proteins in human cancers and loss of PTEN expression promotes tumor formation (60 -62) . Consequently, understanding the molecular mechanisms regulating PTEN expression and function are undoubtedly critical for the prevention of and intervention in multiple pathologies associated with the loss of cell polarity.
Relative to mammary glands and HC11 cells expressing ZnT2, PTEN expression was significantly reduced by ϳ30% in the mammary glands of ZnT2ko mice (Fig. 3, A and B) , and by ϳ50% in ZnT2-attenuated cells (Fig. 3, D and E, Fig. S1 ). Because PTEN inhibits AKT activation (63), we used AKT activation as readout to confirm that PTEN activity was repressed. Indeed, we found that AKT activation was enhanced in the mammary glands of ZnT2ko mice (Fig. 3C ) and in ZnT2KD cells (Fig. 3F) , verifying functional consequences of PTEN degradation. Studies in neurons and airway epithelial cells show that Zn 2ϩ induces PTEN degradation through the ubiquitin- 
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proteasome pathway (63, 64) . Importantly, we previously showed that cytoplasmic Zn 2ϩ accumulates in the MECs of lactating ZnT2-null mice and in ZnT2-attenuated MECs cultured in vitro (27) . This led us to hypothesize that cytoplasmic Zn 2ϩ accumulation in ZnT2-attenuated MECs is the factor behind reduced PTEN expression and disruption of polarity establishment. To test this, we briefly treated ZnT2-attenuated MECs with a modest amount of the Zn 2ϩ chelator N,N,NЈ,NЈ-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) and found that PTEN abundance was indeed restored (Fig. 3 , G and H). A possible mechanism by which the loss of ZnT2 leads to Zn 2ϩ -mediated PTEN degradation may be through ubiquitination and proteasomal degradation (63) . To test this hypothesis, ZnT2-expressing and ZnT2-attenuated cells were pretreated with the proteasome-specific inhibitor MG132, and PTEN protein abundance was evaluated by immunoblotting. As previously discussed, ZnT2 attenuation significantly decreased PTEN abundance. In comparison, pretreatment with MG132 blocked the loss of PTEN in ZnT2-attenuated cells (Fig. 3, I and J) and reduced AKT activation (Fig. 3K ). Taken together, these results indicate that the loss of ZnT2-mediated Zn 2ϩ transport into intracellular vesicles increases cytoplasmic Zn 2ϩ and PTEN degradation through the proteasomal pathway in MECs.
We next examined membrane recruitment of key polarity factors downstream of PTEN activity. In ZnT2-expressing cells, Axn2 staining could be observed at the cell periphery, indicating successful membrane recruitment by PTEN (Fig. 4A) . However, Axn2 was retained proximal to the nucleus and failed to traffic to the membrane in ZnT2-attenuated MECs. This was confirmed by the loss of Axn2 co-localization with PKH26, a 
cell membrane maker, in ZnT2-attenuated cells (Fig. 4 , B and C). Similarly, Cdc42 was primarily detected in the membrane fraction isolated from ZnT2-expressing cells (Fig. 4D) , whereas, in contrast, Cdc42 was more evenly distributed between the cytosolic and membrane fractions in ZnT2-attenuated MECs. Disrupted membrane recruitment of Axn2 and Cdc42 implies the loss of asymmetric segregation, which is a key feature for epithelial polarization (3) .
The loss of polarity may result in numerous deleterious consequences including receptor trafficking and degradation (65) . We previously reported that the mammary glands of lactating ZnT2-null mice and ZnT2-attenuated MECs had reduced STAT5 activation (27) . Because PRL binding to PRLR on the cell surface activates Jak2/STAT5 signaling and regulates mammary gland differentiation, milk production, and secretion during lactation (66), we hypothesized that impaired secretory function resulting from the loss in polarity is due to a failure to respond appropriately to PRL. Both confocal imaging ( Fig. 4E ) and cell-surface biotinylation studies (Fig. 4 , F and G) confirmed that PRLR was detected on the cell surface in ZnT2-expressing cells; however, PRLR was absent from the cell surface and instead, was retained proximal to the nucleus in 
ZnT2-attenuated cells. Collectively, this demonstrates that the loss of ZnT2 impairs polarity and disrupts PRLR trafficking to the cell surface, which is consistent with impaired PRL signaling and defects in mammary gland differentiation and secretion that we previously observed (27) . Interestingly, we previously reported that PRL increases ZnT2 expression (67) . Our observations herein suggest that whereas PRL signaling is required to induce ZnT2 expression, ZnT2 is required to appropriately traffic PRLR to the cell surface to further facilitate PRL signaling in the MECs. Collectively this illustrates the importance of ZnT2 in mammary gland function. Moreover, our observations suggest that ZnT2 dysfunction may impair the overall process of membrane protein trafficking; however, further studies are required to explore this possibility.
Loss of ZnT2 disrupted V-ATPase assembly in the mammary gland in vivo
Following polarity establishment, secretory function is fully achieved when the secretion pathway is activated to deliver cargo to and across the cell membrane (1). In the mammary gland, the MECs actively synthesize copious amounts of caseins and other milk constituents that are secreted into the alveolar lumen, primarily by exocytosis (68) . Vesicle acidification is required for exocytosis in other specialized secretory tissues, such as the pancreas (69), intestine (70) , prostate (71), brain (72) , and salivary gland (73) . To generate acidified vesicles, V-ATPase functions as a proton pump to transport protons into the vesicular lumen (17) . V-ATPase is a multisubunit complex that is composed of two domains, the cytoplasmic V1 domain and the membrane-bound V0 domain (74, 75 ) that assemble and transport protons upon activation (76) . We previously reported that V-ATPase is expressed in the mammary gland (25) , and a recent study indicates that deletion of the V-ATPase subunit V0a2 in mice interferes with TGF␤ and Notch signaling, compromising mammary gland development during puberty. Moreover, deletion of V0a2 was also associated with lactation defects, which was assumed to be from morphological defects acquired during development (20) . Another possibility is that the lack of V-ATPase activity leads to lactationspecific consequences, as vesicle acidification is required for the secretory function of other specialized secretory tissues (13) (14) (15) (16) 18) . To first provide evidence that V-ATPase plays a specific role in lactation, we showed that expression of the primary membrane-associated regulatory subunit V0a was ϳ2-fold 
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greater and cytoplasmic-associated subunit V1B was ϳ3-fold greater in the lactating mammary gland compared with that in nulliparous mice (Fig. 5, A and B) . We next reasoned that if vesicle acidification is an important component of lactation, then the cytoplasmic regulatory subunit V1B would be associated with vesicle membranes to promote V-ATPase assembly and proton transport. Indeed, this is what was observed in wt mice (Fig. 5C ), indicating that V-ATPase assembly, and thus proton transport, was activated. In contrast, we found that in ZnT2ko mice, V1B was retained in the cytoplasm and possibly accumulated in large distinct puncta. It is important to note that this difference occurred despite the lack of an effect on total protein level of either V-ATPase domains (Fig. 5, D and E) , indicating that the loss of ZnT2 affected V-ATPase assembly.
ZnT2 is required for the formation of acidified vesicles and secretion in MECs
Similar to what we observed in the mammary glands of lactating mice, MECs that were fully differentiated to secrete following treatment with PRL for 24 h also had significantly greater expression of the subunit V0a (but not V1B) compared with non-secreting MECs (Fig. 6, A and B) . This suggests that although PRL may be a primary regulator of V0a, V1B is regulated by other lactogenic factors that remain to be identified. We previously showed that ZnT2-null mice had defects in secretion (27) , and that ZnT2-attenuated MECs were unable to generate acidic vesicles (lysosomes) in response to TNF␣ stimulation (19); however, it remains unclear as to if, and how the loss of ZnT2 impairs vesicle acidification. To address this gap in knowledge, we first showed that ZnT2 was co-localized with assembled V-ATPase (Fig. 6C) . Moreover, we found a direct interaction between ZnT2 and V-ATPase under basal, unstimulated conditions, as both the V0a and V1B subunits were detected in ZnT2 immunoprecipitates from non-secreting MECs (Fig. 6D, Fig. S2 ). This interaction was confirmed by the detection of ZnT2 in both V0a and V1B immunoprecipitates, separately (Fig. 6, E and F) . Importantly, we found that the interaction between ZnT2 and V-ATPase (both V0a and V1B subunits) was enhanced in MECs that were differentiated with PRL to form a secreting MEC (Fig. 6, G and H) , providing compelling evidence that ZnT2 and V-ATPase cooperate to promote vesicular Zn 2ϩ and proton accumulation for secretion in MECs.
We next measured vesicle acidification directly, using Lysosensor Blue/Yellow DND-160. As a positive control, cells were treated for 5 min with 5 mM glucose, which is known to stimulate V-ATPase-dependent acidification (77) . The significant reduction in vesicular pH (from pH 5.4 to 5.0) following glucose treatment validated our tool for measuring vesicle acidification in MECs (Fig. 7, A and B) . Several important findings were made. Importantly, and consistent with a key role for vesicular acidification in secretion in MECs, we found that the vesicular pH was significantly lower in MECs treated with PRL compared with non-secreting MECs (Fig. 7, A-D) , providing the first evidence that secretory vesicles in MECs become acidified during differentiation. In addition, the size and number of acidic vesicles in PRL-treated cells were significantly greater (Fig. 7, C-F) , consistent with a role for PRL in vesicle biogenesis and establishing the vesicle secretory system. We noted that ZnT2-attenuation in isolation had a minimal effect on vesicular pH in nonsecreting cells; however, the effect of PRL on increasing vesicle acidification was abolished in ZnT2-attenuated MECs (Fig. 7, C  and D) . It is important to note that this difference occurred despite no change in total protein level of either V-ATPase domains (Fig. S3) . Moreover, ZnT2-attenuation significantly reduced vesicle size (ϳ50%), slightly reduced vesicle number (ϳ25%), and impaired the ability of PRL to activate vesicle biogenesis (Fig. 7, E and F) , providing evidence that ZnT2 is critical for secretory vesicle biogenesis. Vesicular Zn 2ϩ has been previously shown to regulate V-ATPase function and acidification in gastric parietal cells and kidney epithelial cells (78, 79) . It has Figure 5 . Loss of ZnT2 affects V-ATPase assembly in the mammary gland. A, representative immunoblot of V0a and V1B subunits of V-ATPase in lysates from non-lactating (Non-lact) and lactating (Lact) mouse mammary glands. ␤-Actin served as a loading control. B, data represent mean V0a or V1B/␤-actin ratio relative to Non-lact Ϯ S.D., n ϭ 4 mice/group; **, p Ͻ 0.01. C, representative images of V1B (green) in mammary gland sections from lactating wild-type (wt) and ZnT2-null (ZnT2ko) mice. Nuclei were counterstained with DAPI (blue). Note the membrane staining of V1B in the mammary glands of wt mice and the punctate staining of V1B in ZnT2ko mice. Magnification, ϫ20 (top), ϫ63 (bottom). Scale bar, 50 m. D, representative immunoblot of V0a and V1B subunits in lysates from wt and ZnT2ko mammary glands. E, data represent mean V0a or V1B/␤-actin ratio relative to wt Ϯ S.D., n ϭ 4 mice/genotype.
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been reported that Zn 2ϩ accumulation interferes with V-ATPase activity (80) . Therefore we treated cells with PRL, exposed them to a small amount of the Zn 2ϩ chelator TPEN, and then measured vesicle pH. Once again, we found that ZnT2-attentuated cells lost the ability to activate vesicle acidification in response to PRL. Importantly, the presence of TPEN did not remediate this effect (Fig. 7, G and H) . This suggests that the role of ZnT2 in PRL-stimulated vesicle acidification and biogenesis may be independent of its function in Zn 2ϩ transport. Although the mechanisms are not yet understood, PRL likely regulates numerous transcription factors, cell cycle proteins, miRNAs, and lipid mediators that are critical for vesicle biogen- 
esis (81, 82) , which may be impaired by the loss of ZnT2. Further studies are required to determine the molecular interaction between ZnT2 and V-ATPase, and mechanisms through which ZnT2 regulates vesicle biogenesis and acidification in MECs.
Polarized MECs actively synthesize copious amounts of caseins and other milk constituents (83) (84) (85) that are packaged into vesicles for secretion into the alveolar lumen by exocytosis (68) . We reasoned that if vesicle acidification is important for vesicle secretion in MECs, then V-ATPase should co-localize with major milk proteins, and impaired acidification should reduce vesicle secretion. Indeed we found that V-ATPase and ␤-casein were largely co-localized in secretory vesicles (Fig.  8A) . However, in ZnT2-attenuated MECs, V-ATPase and ␤-casein were significantly less co-localized (Fig. 8B) , consistent with a role for ZnT2 as an interacting partner of V-ATPase in secretory vesicle biogenesis and secretion. To determine whether the loss of ZnT2 affects vesicle secretion directly, we transfected cells with GFP-tagged ␤-casein and found that although ZnT2-expressing cells successfully formed and trafficked ␤-casein-containing vesicles toward the cell surface in response to PRL, ␤-casein was retained in the perinuclear 
region in ZnT2-attenuated MECs (Fig. 8C) . This was similar to defects seen in MECs treated with Bafilomycin A1, a specific inhibitor of V-ATPase, and also in V-ATPase-attenuated cells (Fig. 8C, Fig. S4 ). Our data suggest that this defect was not due to cytoplasmic Zn 2ϩ accumulation, as ␤-casein continued to traffic to the cell surface in response to PRL in control cells, and remained perinuclear in ZnT2-attenuated MECs when treated with TPEN (Fig. 8C) . Again, these findings suggest that the role of ZnT2 in regulating vesicle secretion is independent of its function in Zn 2ϩ transport, and are consistent with our findings on the role of Zn 2ϩ in the acidification of secretory vesicles. These studies are consistent with the reduction in milk ␤-casein levels observed in lactating ZnT2ko mice, and decreased ␤-casein secretion into conditioned medium that was previously noted in ZnT2-attenuated MECs (27) , and we now propose that these defects may be due to impaired vesicle biogenesis and/or trafficking. This effect was not specific to large ␤-casein-containing vesicles as we similarly found that lysozyme secretion into conditioned medium was also reduced by ZnT2-and V-ATPase-attenuation and Bafilomycin A1 treatment (Fig. 8D) . In addition to playing a role in vesicle biogenesis and acidification, ZnT2-mediated Zn 2ϩ transport into secretory vesicles might play a direct role in packaging specific components for secretion into milk. For instance, a considerable amount of Zn 2ϩ binds to caseins to allow the maturation into casein micelles (86 -88) . It is likely that other constituents of secretory vesicles in the MECs may be influenced by the absence of vesicular Zn 2ϩ , including lactoferrin (89, 90), immunoglobulin A (90), and lysozyme (91) . In addition, Lavoie et al. (92) showed that vesicular Zn 2ϩ is required for calcium-stimulated vesicle trafficking. Thus, the loss of ZnT2 function may interfere with secretion in MECs by impairing 1) biogenesis; 2) acidification; 3) packaging; and/or 4) trafficking of secretory vesicles to the cell surface.
In summary, this study provides four principal sets of observations on the functional role of ZnT2 in the establishment of secretory function in MECs (Fig. 9) . We demonstrated that 1) ZnT2-mediated Zn 2ϩ transport regulates PTEN stability and activity, which is required for establishing MEC polarity and luminal development; 2) the establishment of polarity in MECs is required for PRLR trafficking and thus PRL signaling; 3) V-ATPase and vesicle acidification are required for secretory function in MECs; and 4) V-ATPase and ZnT2 directly interact to facilitate proton transport, vesicle acidification, and secre- 
tion. Moreover, defects in ZnT2 function in the mammary gland may have broader health implications beyond lactation. For example, impairments in MEC polarity drives breast tumorigenesis (93) (94) (95) . In addition, vesicle biogenesis/trafficking may promote sustained activation of key growth and developmental pathways such as those mediated through EGFR (65), Notch, and TGF-␤ signaling (20) , which also contribute to breast tumorigenesis (96 -98) . Although we previously proposed a role for ZnT2-mediated Zn 2ϩ homeostasis in regulating breast tumor development (99) , further studies are required to explore this relationship.
Experimental procedures
Mice
All animal experiments were approved by the Institutional Animal Care and Use Committee at the Pennsylvania State University, which is accredited by the American Association for the Accreditation of Laboratory Animal Care. Wild-type (wt) and ZnT2-null (ZnT2ko) mice were generated as previously described (27) . Mice were housed in polycarbonate-ventilated cages and fed a standard commercial rodent diet (LabDiet, Quakertown, PA) ad libitum. They were maintained on a 12-h light/dark cycle under controlled temperature and humidity. To study the role of ZnT2 in the mammary gland on secretory function, wt and ZnT2ko female mice were mated with a wt male (2:1 ratio) for 2 weeks, allowed to deliver naturally and nurse their litters up to lactation day (LD) 10. Mice were euthanized by CO 2 asphyxiation and tissues were immediately excised and fixed in 4% paraformaldehyde or Karnovsky's fixative for further analyses.
Histological analysis
Mammary glands were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) overnight, embedded in paraffin, and sections (5 m) were stained with hematoxylin and eosin (H&E) or immunostained as previously described (27) . The following antibodies were used for immunostaining: anti-E-cadherin (adherence junction protein, 1:50; Sigma), antizonula occludens-1 (ZO-1, tight junction protein, 1 g/ml; Abcam, Cambridge, MA), anti-ATP6V0A2 (V0a domain, 1 g/l; Sigma), and anti-V-ATPase B1/2 (V1 domain, 1:200; Santa Cruz Biotechnology). Antibodies were either visualized with Vectastain ABC Kit (Vector Labs, Burlingame, CA) and then counterstained with toluidine blue (E-cadherin), or with Alexa Fluor 488 (ZO-1 and V-ATPase) and then counterstained with DAPI nuclear stain (Thermo Fisher Scientific, Waltham, MA). Stained sections were examined using the Leica DM IL LED microscope equipped with a digital Leica DFC425 camera (Leica Microsystems, Buffalo Grove, IL), or the Leica SP8 Inverted Confocal Microscope (Leica Microsytems). Lumen area was measured using Adobe Photoshop CS6 in all intact alveoli identified in five random images (ϫ10) from one inguinal mammary gland per mouse (n ϭ 4 mice/genotype). Defective expansion in ZnT2ko mice or ZnT2KD cells was indi- 
ZnT2 regulates secretory function
cated when an alveoli had a luminal area smaller than the smallest luminal area identified in wt mice or ZnT2-expressing mammospheres. The percent of alveoli with expanded lumen was calculated as the number of mature alveoli/total number alveoli in five random images (ϫ10) at ϫ100%.
Transmission electron microscopy
Excised mammary glands were immediately harvested in Karnovsy's fixative (4% paraformaldehyde, 1 M sodium hydroxide, 25% glutaraldehyde, 0.2 M sodium cacodylate, pH 7.3) for 24 h and stored in sodium cacodylate (0.1 mM) until processed and imaged as previously described (27) using a JEOL JEM1400 Digital Capture Transmission Electron Microscope at the Penn State Hershey College of Medicine Imaging Facility.
Cell culture and transfection
Mouse MECs (HC11 cells) were a gift from Dr. Jeffery Rosen (Baylor College of Medicine, Houston, TX) and used with permission of Dr. Bernd Groner (Institute for Biomedical Research, Frankford, Germany). HC11 cells were maintained in growth medium (RPMI 1640 supplemented with 10% fetal bovine serum, insulin (5 g/ml), epidermal growth factor (10 ng/ml), and gentamycin). ZnT2 or V-ATPase was attenuated by transfecting cells with siRNA targeted against ZnT2 (5Ј-CCAUCUGCCUGGUGUUCAU-3; Sigma) or ATP6V0A2 (V-ATPase subunit V0; (SASI_Mm01_00029260; Sigma) using Lipofectamine 2000 (Thermo Fisher) as previously described (100) . Cells were differentiated with prolactin (PRL; 1 g/ml) and cortisol (2 M) for 24 h where indicated. Cells were pretreated with cycloheximide (10 M for up to 3 h) to inhibit protein translation, MG132 (10 M for 3 h) to inhibit proteasomal degradation, TPEN (10 M for 2 h) to selectively chelate Zn 2ϩ , or Bafilomycin A1 (10 M for 1 h) to specifically inhibit V-ATPase, where indicated.
Mammospheres in 3D culture
HC11 cells were plated on coverslips coated with 50 l of growth factor-reduced Matrigel (Corning Life Sciences, Corning, NY). After attachment on Matrigel, cells were transfected with ZnT2 siRNA as described above. Cells were maintained in growth medium for 2-3 days and then treated with differentiation medium (1 g/ml of PRL, 2 M cortisol, 5 g/ml of insulin) for 4 days to differentiate and form alveoli. Mammospheres were fixed in 4% paraformaldehyde for 10 min at room temperature and permeabilized with 0.5% Triton X-100/PBS for 10 min at 4°C. After three rinses with 100 mM glycine/PBS, the mammospheres were blocked with immunofluorescence (IF) buffer (130 mM NaCl, 7 mM Na 2 HPO 4 , 3.5 mM NaH 2 PO 4 , 7.7 mM NaN 3 , 0.1% BSA, 0.2% Triton X-100, 0.05% Tween 20) containing 10% goat serum, and then incubated with primary antibody (anti-mouse ZO-1; 5 g/ml) diluted in IF buffer containing 10% goat serum overnight at 4°C. Following three 15-min washes with IF buffer, mammospheres were incubated with secondary antibody (goat anti-mouse IgG labeled with Alexa Fluor 488) for 1 h at room temperature. Following three 15-min washes with IF buffer, nuclei were counterstained with DAPI nuclear stain (0.5 ng/ml) diluted in PBS for 15 min at room temperature. Mammospheres were mounted with Prolong Diamond Reagent (Thermo Fisher) and examined using the Leica Inverted Confocal Microscope SP8. Alveolar area (total mammosphere size) and diameter (lumen size) were measured using Adobe Photoshop CS6 in five random intact mammospheres/group imaged at ϫ20.
Immunofluorescence
HC11 cells were immunostained as previously described (29) . Briefly, cells were fixed with 4% paraformaldehyde for 10 min, permeabilized with 0.2% Triton X-100 for 10 min, and stained with the following antibodies: anti-E-cadherin (1:50), anti-ZO-1 (5 g/ml), anti-annexin 2 (Axn2; 1:50; Santa Cruz Biotechnology), anti-V-ATPase a0 (1 g/l); anti-V-ATPase B1/2 (1:200), anti-PRLR (5 g/ml; Invitrogen), anti-␤-casein (1:200; Santa Cruz), PKH26 (1:500; Sigma) or anti-HA (1:1000; Sigma). Primary antibodies were visualized using secondary antibodies conjugated with Alexa Fluor 488 or Alexa Fluor 568, counterstained with DAPI nuclear stain, and mounted with Prolong Diamond Reagent. Slides were examined using the Leica SP8Inverted Confocal Microscope.
Immunoblotting
Tissue and cell lysates were homogenized in buffer (20 mM HEPES, 1 mM EDTA, 250 mM sucrose, pH 7.4) containing protease inhibitors and the total cell lysate or membrane fractions were prepared as previously described (101) . Proteins were separated by SDS-PAGE electrophoresis and transferred onto nitrocellulose membrane. The following antibodies were used: anti-PTEN (1:200; Santa Cruz Biotechnology), anti-PRLR (5 g/ml), anti-Cdc42 (1:1000; Cell Signaling, Danvers, MA), anti-p-AKT (1:1000; Cell Signaling), anti-AKT (1:1000; Cell Signaling), anti-ATP6V0A2 (1 g/l), and anti-V-ATPase B1/2 (1:200). Antibodies were detected with horseradish peroxidaseconjugated anti-rabbit, -mouse, or -goat IgG (Thermo Fisher Scientific). Membranes were stripped before re-probing with another antibody or ␤-actin (1:5000, Sigma) as loading or normalization controls where indicated. Protein was detected with a SuperSignal Femto Chemiluminescent Detection System (Thermo Fisher Scientific) and imaged using digital imaging (FluorChem M, Cell Biosciences, USA). Band signal intensity was quantified using AlphaView software (ProteinSimple, San Jose, CA). All spliced images were from a single immunoblot; the area of vertical splicing was indicated with a dotted line.
Cell-surface biotinylation of PRLR
N-Hydroxysulfosuccinimide biotin (Thermo Fisher Scientific) was used to label cell-surface proteins to detect PRLR at the cell surface as described previously (32) . Biotinylated proteins were eluted by heating to 95°C in Laemmli buffer containing 100 mM dithiothreitol, electrophoresed using SDS-PAGE, transferred to nitrocellulose membrane, and immunoblotted with anti-PRLR antibody (5 g/ml) as described above. Protein was detected with SuperSignal Femto Chemiluminescent Detection System and imaged using digital imaging. Band signal intensity was quantified using AlphaView software.
ZnT2 regulates secretory function Membrane recruitment of Cdc42
HC11 cell lysates were collected in homogenization buffer, sonicated briefly, centrifuged at 500 ϫ g for 5 min to remove debris, and a sample of supernatant (cell lysate) was set aside (total). The supernatant was further centrifuged at 100,000 ϫ g for 30 min to pellet the total membrane fraction and isolate the cytosolic fraction. Cell lysate, cytosolic and membrane fractions (20 g) were loaded on a 10% SDS-polyacrylamide gel and immunoblotted for Cdc42 to assess the recruitment of Cdc42 to the membrane, as described above. Ponceau staining was used as loading control.
Secretory function
Large vesicles-To monitor the secretion of large (ϳ1 m) vesicles, HC11 cells were plated on a 24-well plate, grown until ϳ80% confluent, and transfected with plasmid (0.8 g/well) containing Green Fluorescent Protein (GFP)-tagged ␤-casein (Cambridge Bioscience, Cambridge, UK). Cells were pretreated with cycloheximide (100 g/ml) and held at room temperature (20°C) for 3 h to stop protein translation, and then treated with PRL (1 g/ml) and cortisol (2 M) for up to 60 min to stimulate secretion. In some experiments, cells were pretreated with TPEN (10 M for 2 h). Cells were fixed as described above and GFP-tagged ␤-casein was imaged at discrete time points (0, 15, 30, and 60 min).
Small vesicles-To monitor the secretion of small (ϳ200 nm) vesicles, HC11 cells were grown on 96-well plates and differentiated with PRL (1 g/ml) and cortisol (2 M) for 24 h. Medium was removed and then cells were treated for an additional 12 h with PRL (1 g/ml) and cortisol (2 M) and either Bafilomycin A1 (1 M in DMSO) or DMSO (control). Conditioned medium was collected and assayed for lysozyme activity using EnzChek Lysozyme Assay Kit (Thermo Fisher Scientific) according to the manufacturer's instructions.
Immunoprecipitation
HC11 cells were cultured in 6-well dishes, washed in ice-cold PBS, and lysed with radioimmunoprecipitation (RIPA) buffer for 5 min on ice. Cells were scraped into microcentrifuge tubes and sonicated on ice, then centrifuged for 10 min at 14,000 ϫ g at 4°C. The protein concentration of the clarified supernatants was determined using the Bradford assay. Lysates were incubated with 5 g of antibody (anti-HA, -V0, or -V1) for 3 h followed by Protein A-agarose beads (Sigma) for 1 h at 4°C with rotation. The resin was pelleted by centrifugation at 10,000 ϫ g for 1 min and washed four times with RIPA buffer. Following the final wash, sample buffer was added to the resin and proteins were eluted and denatured by heating at 95°C for 5 min. Samples were vortexed and centrifuged at 10,000 ϫ g for 5 min to pellet the resin. Supernatants were loaded onto a 10% polyacrylamide gel and immunoblotting was performed as described above. Total cell lysates were used as an input control.
Vesicle pH
Vesicle pH was measured using Lysosensor Blue/Yellow DND-160 (Thermo Fisher Scientific). HC11 cells were loaded with Lysosensor Blue/Yellow DND-160 (5 M diluted in Opti-MEM) for 1 h at 37°C. After a brief rinse with PBS, cells were imaged using a Leica SP8 inverted confocal microscope. The cells were excited at 405 nm and emitted at two different wavelengths: 455 nm for Lysosensor Blue (channel 1; pH 9) and 540 nm for Lysosensor Yellow (channel 2; pH 3). Imaris 8.2 software (Bitplane, Belfast, UK) was used to measure the fluorescence intensity from channels 1 and 2. The fluorescence intensity from channels 1 and 2 was measured in all vesicles identified in 5 randomly selected cells/image (ϫ63), from 5 images/group. Results were presented as the mean ratio of the fluorescence intensity from channel 1 divided by channel 2 (i.e. blue/yellow). Vesicle pH was determined using a calibration curve constructed by adding 5 M Lysosensor Blue/Yellow DND-160 to Opti-MEM medium held at a specific pH ranging from 4 to 5.5 (in 0.1 increments) and measuring the fluorescence emitted at ϳ535 nm following excitation at ϳ340 (blue) and ϳ380 nm (yellow). The calibration curve was obtained by taking the ratio of emitted fluorescence at the two-excitation wavelengths (i.e. blue/yellow) and plotting the fluorescence ratio against the pH. The size and number of all acidic vesicles in a cell were measured in 4 randomly selected cells/image (ϫ63) from 4 images/ group using Adobe Photoshop CS6.
Statistical analysis
Results are presented as mean Ϯ S.D. unless otherwise noted. All experiments were performed with at least 2-3 replicates, and all experiments were repeated at least three times. Statistical comparisons were performed using two-tailed Student's t tests or one-way analysis of variance with Bonferroni's post hoc test for multiple comparisons (Prism GraphPad). Statistical significance was demonstrated at p Ͻ 0.05.
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